In a report published Wednesday, Morgan Stanley analyst David R. Lewis reiterated an Outperform rating on Nevro Corp NVRO, and raised the price target from $33.00 to $35.00.
In the report, Morgan Stanley noted, “Strong results out of the gate showed upside to both OUS sales and gross margins. Longer-term value creation is more tied to the US launch, which is on track for 1Q16 or earlier. Our price target increases to $35 on stronger OUS traction and better profitability; our bull case moves to $68.”
Nevro closed on Tuesday at $30.10.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in